Fortrea (FTRE) Expected to Announce Earnings on Thursday

Fortrea (NASDAQ:FTRE) will likely be releasing its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect the company to announce earnings of $0.16 per share and revenue of $665.2220 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 26, 2026 at 8:00 AM ET.

Fortrea Trading Up 7.6%

FTRE opened at $10.44 on Thursday. The firm’s fifty day moving average price is $15.91 and its 200 day moving average price is $12.15. Fortrea has a 12-month low of $3.97 and a 12-month high of $18.67. The stock has a market capitalization of $964.66 million, a PE ratio of -0.93, a P/E/G ratio of 0.28 and a beta of 1.59. The company has a debt-to-equity ratio of 1.81, a current ratio of 1.00 and a quick ratio of 1.00.

Wall Street Analyst Weigh In

FTRE has been the topic of a number of research reports. Citigroup raised shares of Fortrea from a “neutral” rating to a “buy” rating and increased their target price for the stock from $12.00 to $21.00 in a report on Thursday, December 11th. Robert W. Baird set a $19.00 price target on shares of Fortrea in a research report on Wednesday, January 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Fortrea in a research report on Thursday, January 22nd. Wall Street Zen downgraded Fortrea from a “buy” rating to a “hold” rating in a report on Monday, October 27th. Finally, Wedbush set a $21.00 price target on Fortrea in a report on Thursday, December 11th. Four research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $16.75.

Hedge Funds Weigh In On Fortrea

Several large investors have recently bought and sold shares of the stock. Osaic Holdings Inc. lifted its position in Fortrea by 74.3% in the second quarter. Osaic Holdings Inc. now owns 6,844 shares of the company’s stock worth $38,000 after purchasing an additional 2,918 shares during the period. Tower Research Capital LLC TRC lifted its holdings in Fortrea by 137.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 8,713 shares of the company’s stock valued at $43,000 after purchasing an additional 5,036 shares during the last quarter. Toronto Dominion Bank acquired a new position in Fortrea in the fourth quarter valued at about $51,000. EverSource Wealth Advisors LLC grew its stake in Fortrea by 662.9% during the second quarter. EverSource Wealth Advisors LLC now owns 11,963 shares of the company’s stock worth $59,000 after buying an additional 10,395 shares during the last quarter. Finally, Franklin Resources Inc. acquired a new stake in shares of Fortrea during the second quarter worth approximately $60,000.

Fortrea Company Profile

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific’s Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company’s comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea’s core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.